4Chim H, Tan BH, Ang CC. The prevalence of menopausal symptoms in a commcuity in singapore[J]. Maturitas, 2002 , 41(4) :275-282.
5Harlow BL,Cohen LS,Otto MW,et al. Prevalence and predictors of depressine symptoms in older pre-menopausal women[J]. Arch Gen Psychiaty, 1999,56(5) :418-424.
6Paul AK. Estrogen supplementation attenuates glucocorticid and catecholamine reponses to mental stress in perimenopausal women[J]. Journal of Clinical Endocrinoloty and Metobolism, 2003,84(2) ,606.
7Giammell G,Gasperi MG, Bandieri PV. Melitracenflupentixol association for outpatient treatment of depression and anxiety[J ]. European Review for Medical and Pharmacological Science, 2003,7 : 175- 181.
8Schmidt PJ, Murphy JH, Hap N, et al. Stressful life events,presonal losses, and perimenopause related depression [J].Arch Women Merit Heacth, 2004,7 ( 1 ) : 19 - 26.
9Bloch AC. A psychological approach to menopausal complaints in reply to Desoto's comments[J]. Maturitas,2003,45(4) ,303-304.
7Murakumi J. Gender and depression: Explaining the Different Rates of Depression Between Men and Women[J]. Perspectives in Psychology Spring, 2002:27-34.
8Kornstein S G. Chronic depression in women [J]. J ,Clin Psychiatry, 2002,63: 602-609.
9Kornstein S G, Schatzberg A F, Thase M E, et al. Gender differences in treatment response to sertraline versus imipramine in chronic depression[J]. Am J Psychiatry, 2000,157(9):1445-1452.
10Bies R R, Bigos K L, Pollock B G. Gender differences in the pharmacokinetics and pharmacodynamics of antidepressants [J]. J Gend Specif Med,2003,6(3):12-20.
